» Articles » PMID: 9806168

Metabolism of Benzo[a]pyrene and Benzo[a]pyrene-7,8-diol by Human Cytochrome P450 1B1

Overview
Journal Carcinogenesis
Specialty Oncology
Date 1998 Nov 7
PMID 9806168
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Benzo[a]pyrene (B[a]P), a ubiquitous environmental, tobacco and dietary carcinogen, has been implicated in human cancer etiology. The role of human cytochrome P450 1B1 in the metabolism of B[a]P is poorly understood. Using microsomal preparations of human P450 1A1, 1A2 and 1B1 expressed in baculovirus-infected insect cells, as well as human and rat P450 1B1 expressed in yeast, we have determined the metabolism of B[a]P, with and without the addition of exogenous epoxide hydrolase, and B[a]P-7,8-dihydrodiol (7,8-diol), each substrate at a concentration of 10 microM. HPLC analysis detected eight major metabolites of B[a]P and four metabolites of the 7,8-diol. The results of these studies indicate that cytochrome P450 1B1 carries out metabolism of B[a]P along the pathway to the postulated ultimate carcinogen, the diol epoxide 2, at rates much higher than P450 1A2 but less than P450 1A1. The rates of formation of the 7,8-diol metabolite in incubations with epoxide hydrolase are 0.17 and 0.38 nmol/min/nmol P450 for human P450 1B1 and 1A1, respectively, and undetectable for 1A2. The rates of total tetrol metabolite formation from the 7,8-diol, which are indicative of diol epoxide formation, are 0.60, 0.43 and 2.58 nmol/min/nmol P450 for 1B1, 1A2 and 1A1 respectively. In agreement with other reports of rat P450 1B1 activity, our data show this rat enzyme to be very active for B[a]P and 7,8-diol, with rates higher than human P450 1B1. In addition to the established role of P450 1A1 in B[a]P metabolism, P450 1B1 may significantly contribute to B[a]P and 7,8-diol metabolism and carcinogenesis in rodent tumor models and in humans.

Citing Articles

Genetic and epigenetic modulations in toxicity: The two-sided roles of heavy metals and polycyclic aromatic hydrocarbons from the environment.

Adegbola P, Adetutu A Toxicol Rep. 2024; 12:502-519.

PMID: 38774476 PMC: 11106787. DOI: 10.1016/j.toxrep.2024.04.010.


Impact of phenanthrene co-administration on the toxicokinetics of benzo[a]pyrene in humans. UPLC-accelerator mass spectrometry following oral microdosing.

Vermillion Maier M, Siddens L, Pennington J, Uesugi S, Labut E, Vertel E Chem Biol Interact. 2023; 382:110608.

PMID: 37369263 PMC: 10782561. DOI: 10.1016/j.cbi.2023.110608.


Zearalenone and its metabolite exposure directs oestrogen metabolism towards potentially carcinogenic metabolites in human breast cancer MCF-7 cells.

Malekinejad F, Fink-Gremmels J, Malekinejad H Mycotoxin Res. 2022; 39(1):45-56.

PMID: 36517666 DOI: 10.1007/s12550-022-00472-0.


Competitive Metabolism of Polycyclic Aromatic Hydrocarbons (PAHs): An Assessment Using In Vitro Metabolism and Physiologically Based Pharmacokinetic (PBPK) Modeling.

Smith J, Gaither K, Pande P Int J Environ Res Public Health. 2022; 19(14).

PMID: 35886113 PMC: 9323266. DOI: 10.3390/ijerph19148266.


Rapid fluorescence immunoassay of benzo[]pyrene in mainstream cigarette smoke based on a dual-functional antibody-DNA conjugate.

Fan Z, Li Z, Liu S, Yang F, Bian Z, Wang Y RSC Adv. 2022; 8(52):29562-29569.

PMID: 35547323 PMC: 9085264. DOI: 10.1039/c8ra04915g.